Wang, Suming
Zota, Victor
Vincent, Melanie Y.
Clossey, Donna
Chen, Jian Jenny
Cieslewicz, Michael
Watnick, Randolph S.
Mahoney, James
Watnick, Jing
Article History
Received: 24 June 2024
Accepted: 25 November 2024
First Online: 3 December 2024
Competing interests
: Vigeo Therapeutics designed VT1021 and sponsored the trial in this article. V.Z. is a consultant for Vigeo Therapeutics. R.S.W. is a co-founder of, and consultant for, Vigeo Therapeutics, which has licensed technology from Boston Children’s Hospital. S.W., M.Y.V., D.C., J.J.C., M.C., J.M., and J.W. are employees of Vigeo Therapeutics.